VANCOUVER, BC / ACCESSWIRE / November 4, 2024 / StimCell Energetics Inc. (formerly "Cell MedX Corp.") (OTC PINK:CMXC) ("StimCell", or the "Company") a biotech company targeting cellular energy to ...
VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / February 25, 2025 / StimCell Energetics Inc. (OTC PINK:STME) ("StimCell" or the "Company"), a biotech pioneer targeting cellular energy to enhance ...
The most prevalent human diseases in industrialized countries include obesity, type 2 diabetes, cancer, neurodegenerative, and cardiovascular diseases. A common feature of these ailments is ...
Our research focusses on mitochondria, cellular energetics, reactive oxygen species and their roles in physiology, disease, and aging. We have approached each by using the tools of biochemistry, ...
Effective immediately, the Company has completed a corporate name change from "Cell MedX Corp." to "StimCell Energetics Inc." and completed a reverse split of its common stock on a 1 new share for 15 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results